BAC:NYSEBank of America Corporation Analysis
Data as of 2026-06-13 - not real-time
$56.02
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Technical momentum remains robust: the stock is trading above its short‑ and long‑term moving averages, the MACD is in a bullish configuration and volume is stable, indicating continued upward pressure despite the RSI hovering in the overbought zone. The price is comfortably above the nearest support level and is approaching a key resistance ceiling.
Fundamentals support the upside: valuation metrics show a price‑to‑earnings multiple comfortably below the industry average, while profitability ratios such as ROE and operating margin are solid. The balance sheet is net‑cash positive, and the company is returning capital to shareholders through dividends and sizable buybacks. The launch of a new cross‑border real‑time payments platform adds a clear growth catalyst to the earnings narrative.
Valuation and market sentiment align for a potential rally: discounted cash‑flow analysis points to a fair value well above the current price, and the consensus analyst rating is a strong‑buy with a median target that implies meaningful upside. Market sentiment is at an extreme‑greed level, reinforcing the bullish bias, though some technical warning signals merit monitoring.
Fundamentals support the upside: valuation metrics show a price‑to‑earnings multiple comfortably below the industry average, while profitability ratios such as ROE and operating margin are solid. The balance sheet is net‑cash positive, and the company is returning capital to shareholders through dividends and sizable buybacks. The launch of a new cross‑border real‑time payments platform adds a clear growth catalyst to the earnings narrative.
Valuation and market sentiment align for a potential rally: discounted cash‑flow analysis points to a fair value well above the current price, and the consensus analyst rating is a strong‑buy with a median target that implies meaningful upside. Market sentiment is at an extreme‑greed level, reinforcing the bullish bias, though some technical warning signals merit monitoring.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish MACD and price above key moving averages
- Strong capital return program boosting investor confidence
- Upcoming cross‑border payments launch providing near‑term revenue tailwinds
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued relative to peers on a PE basis
- Sustainable dividend with modest payout ratio
- Analyst consensus of strong‑buy and upside potential in target price
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Net‑cash position and resilient earnings generation
- Strategic shift toward digital payments and wealth management
- Low beta indicating defensive characteristics in market downturns
Key Metrics & Analysis
Financial Health
Revenue Growth8.10%
Profit Margin28.96%
P/E Ratio13.9
ROE10.64%
ROA0.93%
P/B Ratio1.4
Op. Cash Flow$56.6B
Industry P/E16.8
Technical Analysis
TrendBullish
RSI71.7
Support$49.30
Resistance$56.19
MA 20$52.48
MA 50$52.37
MA 200$52.11
MACDBullish
VolumeStable
Fear & Greed Index89.86
Valuation
Fair Value$111.46
Target Price$63.16
Upside/Downside12.74%
GradeUndervalued
TypeBlend
Dividend Yield2.00%
Risk Assessment
Beta0.86
Volatility22.39%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.